https://www.businessline.global/takeda-presents-positive-results-for-mobocertinib-in-patients-with-egfr-exon20-insertion-mnsclc-who-received-prior-platinum-based-chemotherapy/press-release/
Takeda Presents Positive Results For Mobocertinib in Patients with EGFR Exon20 insertion+ mNSCLC Who Received Prior Platinum-based Chemotherapy